query dict | items listlengths 1 1 |
|---|---|
{
"id": "q_0",
"content": "Naloxone [SEP] Naloxone reverses the antihypertensive effect of clonidine.",
"tokenized_content": [
2,
21926,
3,
21926,
28817,
1920,
16439,
2495,
1927,
26596,
18,
3
]
} | [
{
"id": "p_0",
"content": "Naloxone [SEP] A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid recepto",
"score": 1,
"type": null,
"tokenized_content": [
2,
21926,
3,
43,
2487,
27059,
81... |
{
"id": "q_1",
"content": "clonidine [SEP] Naloxone reverses the antihypertensive effect of clonidine.",
"tokenized_content": [
2,
26596,
3,
21926,
28817,
1920,
16439,
2495,
1927,
26596,
18,
3
]
} | [
{
"id": "p_1",
"content": "Clonidine [SEP] An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonl",
"score": 1,
"type": null,
"tokenized_content": [
2,
26596,
3,
1925,
20697,
10457,
... |
{
"id": "q_2",
"content": "hypertensive [SEP] In unanesthetized, spontaneously hypertensive rats the decrease in blood pressure and heart rate produced by ",
"tokenized_content": [
2,
11706,
3,
1922,
26844,
11682,
20536,
1914,
6756,
16,
12753,
11706,
3615,
1920,
3714,
1922,
2877,
3772,
1930,
4003,
2769,
4152,
2007,
3
]
} | [
{
"id": "p_2",
"content": "Hypertension [SEP] Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is c",
"score": 1,
"type": null,
"tokenized_content": [
2,
5579,
3,
23334,
2149,
5510,
... |
{
"id": "q_3",
"content": "clonidine [SEP] crease in blood pressure and heart rate produced by intravenous clonidine, 5 to 20 micrograms/kg, was inhibited or reversed by nalozone, ",
"tokenized_content": [
2,
26596,
3,
3478,
2051,
1922,
2877,
3772,
1930,
4003,
2769,
4152,
2007,
7307,
26596,
16,
25,
1942,
2036,
13362,
19,
3621,
16,
1982,
5069,
2014,
9432,
2007,
13120,
12852,
2912,
3
]
} | [
{
"id": "p_3",
"content": "Clonidine [SEP] An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonl",
"score": 1,
"type": null,
"tokenized_content": [
2,
26596,
3,
1925,
20697,
10457,
... |
{
"id": "q_4",
"content": "hypotensive [SEP] /kg, was inhibited or reversed by nalozone, 0.2 to 2 mg/kg. The hypotensive effect of 100 mg/kg alpha-methyldopa was also partially reverse",
"tokenized_content": [
2,
12201,
3766,
3,
19,
3621,
16,
1982,
5069,
2014,
9432,
2007,
13120,
12852,
2912,
16,
20,
18,
22,
1942,
22,
2786,
19,
3621,
18,
1920,
12201,
3766,
2495,
1927,
2813,
3
]
} | [
{
"id": "p_4",
"content": "Hypotension [SEP] Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DI",
"score": 1,
"type": null,
"tokenized_content": [
2,
16453,
3,
20756,
2330,
2877,
... |
{
"id": "q_5",
"content": "alpha-methyldopa [SEP] y nalozone, 0.2 to 2 mg/kg. The hypotensive effect of 100 mg/kg alpha-methyldopa was also partially reversed by naloxone. Naloxone alone did not",
"tokenized_content": [
2,
4595,
17,
4963,
22389,
4302,
3,
67,
13120,
12852,
2912,
16,
20,
18,
22,
1942,
22,
2786,
19,
3621,
18,
1920,
12201,
3766,
2495,
1927,
2813,
2786,
19,
3621,
4595,
3
]
} | [
{
"id": "p_5",
"content": "Methyldopa [SEP] An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an ant",
"score": 1,
"type": null,
"tokenized_content": [
2,
4963,
22389,
4302,
3,
1925,
... |
{
"id": "q_6",
"content": "naloxone [SEP] ct of 100 mg/kg alpha-methyldopa was also partially reversed by naloxone. Naloxone alone did not affect either blood pressure or heart r",
"tokenized_content": [
2,
21926,
3,
3369,
1927,
2813,
2786,
19,
3621,
4595,
17,
4963,
22389,
4302,
1982,
2222,
6426,
9432,
2007,
21926,
18,
21926,
4298,
2811,
2084,
4081,
3108,
2877,
3772,
2014,
4003,
3
]
} | [
{
"id": "p_6",
"content": "Naloxone [SEP] A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid recepto",
"score": 1,
"type": null,
"tokenized_content": [
2,
21926,
3,
43,
2487,
27059,
81... |
{
"id": "q_7",
"content": "Naloxone [SEP] mg/kg alpha-methyldopa was also partially reversed by naloxone. Naloxone alone did not affect either blood pressure or heart rate. In br",
"tokenized_content": [
2,
21926,
3,
2786,
19,
3621,
4595,
17,
4963,
22389,
4302,
1982,
2222,
6426,
9432,
2007,
21926,
18,
21926,
4298,
2811,
2084,
4081,
3108,
2877,
3772,
2014,
4003,
2769,
18,
1922,
3
]
} | [
{
"id": "p_7",
"content": "Naloxone [SEP] A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid recepto",
"score": 1,
"type": null,
"tokenized_content": [
2,
21926,
3,
43,
2487,
27059,
81... |
{
"id": "q_8",
"content": "Lidocaine [SEP] Lidocaine-induced cardiac asystole.",
"tokenized_content": [
2,
19567,
3,
19567,
17,
2719,
4435,
1966,
2298,
2456,
18,
3
]
} | [
{
"id": "p_8",
"content": "Lidocaine [SEP] A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more pro",
"score": 1,
"type": null,
"tokenized_content": [
2,
19567,
3,
43,
3076,
16111,
1... |
{
"id": "q_9",
"content": "cardiac asystole [SEP] Lidocaine-induced cardiac asystole.",
"tokenized_content": [
2,
4435,
1966,
2298,
2456,
3,
19567,
17,
2719,
4435,
1966,
2298,
2456,
18,
3
]
} | [
{
"id": "p_9",
"content": "Heart Arrest [SEP] Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most c",
"score": 1,
"type": null,
"tokenized_content": [
2,
4003,
8048,
3,
10975,
1927,
... |
{
"id": "q_10",
"content": "lidocaine [SEP] Intravenous administration of a single 50-mg bolus of lidocaine in a 67-year-old man resulted in profound depression of the act",
"tokenized_content": [
2,
19567,
3,
7307,
4183,
1927,
43,
2957,
2761,
17,
2786,
14840,
1927,
19567,
1922,
43,
4838,
17,
2476,
17,
4156,
2323,
4306,
1922,
11098,
4621,
1927,
1920,
4033,
3
]
} | [
{
"id": "p_10",
"content": "Lidocaine [SEP] A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more pro",
"score": 1,
"type": null,
"tokenized_content": [
2,
19567,
3,
43,
3076,
16111,
... |
{
"id": "q_11",
"content": "depression [SEP] mg bolus of lidocaine in a 67-year-old man resulted in profound depression of the activity of the sinoatrial and atrioventricular nodal pa",
"tokenized_content": [
2,
4621,
3,
2786,
14840,
1927,
19567,
1922,
43,
4838,
17,
2476,
17,
4156,
2323,
4306,
1922,
11098,
4621,
1927,
1920,
2455,
1927,
1920,
3132,
6952,
17075,
1930,
28355,
13926,
3838,
3
]
} | [
{
"id": "p_11",
"content": "Depressive Disorder [SEP] An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood distur",
"score": 1,
"type": null,
"tokenized_content": [
2,
7745,
4770,
3,
1925,
11... |
{
"id": "q_12",
"content": "bradyarrhythmias [SEP] nditions which might have predisposed him to the development of bradyarrhythmias; and, thus, this probably represented a true idiosyncrasy to li",
"tokenized_content": [
2,
20152,
23246,
15519,
3,
8026,
2092,
1036,
2154,
3284,
2162,
23002,
1007,
13135,
1942,
1920,
2740,
1927,
20152,
23246,
15519,
31,
1930,
16,
2842,
16,
2052,
6226,
5960,
43,
6228,
3
]
} | [
{
"id": "p_12",
"content": "Bradycardia [SEP] Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. Th",
"score": 1,
"type": null,
"tokenized_content": [
2,
26192,
3,
4435,
16934,
1988,
... |
{
"id": "q_13",
"content": "Suxamethonium [SEP] Suxamethonium infusion rate and observed fasciculations. A dose-response stud",
"tokenized_content": [
2,
2020,
11414,
23568,
15414,
3,
2020,
11414,
23568,
15414,
7386,
2769,
1930,
2528,
29990,
18021,
6055,
1036,
18,
43,
3253,
17,
2644,
2060,
3
]
} | [
{
"id": "p_13",
"content": "Succinylcholine [SEP] A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxan",
"score": 1,
"type": null,
"tokenized_content": [
2,
13791,
2199,
11603,
3,
43,
... |
{
"id": "q_14",
"content": "fasciculations [SEP] Suxamethonium infusion rate and observed fasciculations. A dose-response study.",
"tokenized_content": [
2,
29990,
18021,
6055,
1036,
3,
2020,
11414,
23568,
15414,
7386,
2769,
1930,
2528,
29990,
18021,
6055,
1036,
18,
43,
3253,
17,
2644,
2161,
18,
3
]
} | [
{
"id": "p_14",
"content": "Fasciculation [SEP] Involuntary contraction of the muscle fibers innervated by a motor unit. Fasciculations can often by visualized and take the for",
"score": 1,
"type": null,
"tokenized_content": [
2,
29990,
18021,
6055,
3,
28493,... |
{
"id": "q_15",
"content": "Suxamethonium chloride [SEP] Suxamethonium chloride (Sch) was administered i.v. to 36 adult males at six rates: 0.2",
"tokenized_content": [
2,
2020,
11414,
23568,
15414,
9140,
3,
2020,
11414,
23568,
15414,
9140,
12,
2966,
13,
1982,
5254,
51,
18,
64,
18,
1942,
3480,
4160,
5129,
2019,
3798,
3389,
30,
20,
18,
3
]
} | [
{
"id": "p_15",
"content": "Succinylcholine [SEP] A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxan",
"score": 1,
"type": null,
"tokenized_content": [
2,
13791,
2199,
11603,
3,
43,
... |
{
"id": "q_16",
"content": "Sch [SEP] Suxamethonium chloride (Sch) was administered i.v. to 36 adult males at six rates: 0.25 mg ",
"tokenized_content": [
2,
2966,
3,
2020,
11414,
23568,
15414,
9140,
12,
2966,
13,
1982,
5254,
51,
18,
64,
18,
1942,
3480,
4160,
5129,
2019,
3798,
3389,
30,
20,
18,
2637,
2786,
3
]
} | [
{
"id": "p_16",
"content": "Succinylcholine [SEP] A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxan",
"score": 1,
"type": null,
"tokenized_content": [
2,
13791,
2199,
11603,
3,
43,
... |
{
"id": "q_17",
"content": "tetanic [SEP] was discontinued either when there was no muscular response to tetanic stimulation of the ulnar nerve or when Sch 120 mg was exceeded.",
"tokenized_content": [
2,
9717,
19510,
3,
1982,
16087,
3108,
2469,
2276,
1982,
2239,
12330,
2644,
1942,
9717,
19510,
4177,
1927,
1920,
24630,
5507,
2014,
2469,
2966,
6103,
2786,
1982,
13862,
18,
3
]
} | [
{
"id": "p_17",
"content": "Tetany [SEP] A disorder characterized by muscle twitches, cramps, and carpopedal spasm, and when severe, laryngospasm and seizures. This cond",
"score": 1,
"type": null,
"tokenized_content": [
2,
9717,
5323,
3,
43,
4770,
4378,... |
{
"id": "q_18",
"content": "Fasciculations [SEP] eded. Six additional patients received a 30-mg i.v. bolus dose. Fasciculations in six areas of the body were scored from 0 to 3 and summated a",
"tokenized_content": [
2,
29990,
18021,
6055,
1036,
3,
3347,
1919,
18,
3798,
3281,
2132,
4004,
43,
2627,
17,
2786,
51,
18,
64,
18,
14840,
3253,
18,
29990,
18021,
6055,
1036,
1922,
3798,
3957,
3
]
} | [
{
"id": "p_18",
"content": "Fasciculation [SEP] Involuntary contraction of the muscle fibers innervated by a motor unit. Fasciculations can often by visualized and take the for",
"score": 1,
"type": null,
"tokenized_content": [
2,
29990,
18021,
6055,
3,
28493,... |
{
"id": "q_19",
"content": "fasciculation [SEP] eas of the body were scored from 0 to 3 and summated as a total fasciculation score. The times to first fasciculation, twitch suppression and",
"tokenized_content": [
2,
29990,
18021,
6055,
3,
4843,
1927,
1920,
3362,
1985,
9032,
2037,
20,
1942,
23,
1930,
4162,
1981,
1966,
43,
2698,
29990,
18021,
6055,
3593,
18,
1920,
3586,
1942,
2561,
29990,
3
]
} | [
{
"id": "p_19",
"content": "Fasciculation [SEP] Involuntary contraction of the muscle fibers innervated by a motor unit. Fasciculations can often by visualized and take the for",
"score": 1,
"type": null,
"tokenized_content": [
2,
29990,
18021,
6055,
3,
28493,... |
{
"id": "q_20",
"content": "twitch [SEP] a total fasciculation score. The times to first fasciculation, twitch suppression and tetanus suppression were inversely related to t",
"tokenized_content": [
2,
21596,
3,
43,
2698,
29990,
18021,
6055,
3593,
18,
1920,
3586,
1942,
2561,
29990,
18021,
6055,
16,
21596,
6412,
1930,
25608,
6412,
1985,
12442,
2712,
1942,
62,
3
]
} | [
{
"id": "p_20",
"content": "Tetany [SEP] A disorder characterized by muscle twitches, cramps, and carpopedal spasm, and when severe, laryngospasm and seizures. This cond",
"score": 1,
"type": null,
"tokenized_content": [
2,
9717,
5323,
3,
43,
4770,
4378,... |
{
"id": "q_21",
"content": "tetanus [SEP] score. The times to first fasciculation, twitch suppression and tetanus suppression were inversely related to the infusion rates. Fasci",
"tokenized_content": [
2,
25608,
3,
3593,
18,
1920,
3586,
1942,
2561,
29990,
18021,
6055,
16,
21596,
6412,
1930,
25608,
6412,
1985,
12442,
2712,
1942,
1920,
7386,
3389,
18,
29990,
3
]
} | [
{
"id": "p_21",
"content": "Tetany [SEP] A disorder characterized by muscle twitches, cramps, and carpopedal spasm, and when severe, laryngospasm and seizures. This cond",
"score": 1,
"type": null,
"tokenized_content": [
2,
9717,
5323,
3,
43,
4770,
4378,... |
{
"id": "q_22",
"content": "Galanthamine hydrobromide [SEP] Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of t",
"tokenized_content": [
2,
5179,
7744,
3812,
3290,
18474,
16408,
1021,
3,
5179,
7744,
3812,
3290,
18474,
16408,
1021,
16,
43,
4872,
8290,
5851,
12074,
21343,
2838,
16,
1922,
1920,
2311,
1927,
62,
3
]
} | [
{
"id": "p_22",
"content": "Galantamine [SEP] A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor tha",
"score": 1,
"type": null,
"tokenized_content": [
2,
5179,
23200,
25157,
3,
43,
... |
{
"id": "q_23",
"content": "scopolamine [SEP] cholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).",
"tokenized_content": [
2,
25392,
10173,
25157,
3,
15440,
2156,
7124,
4127,
2838,
16,
1922,
1920,
2311,
1927,
1920,
4101,
2564,
1927,
25392,
10173,
25157,
12,
4527,
17413,
2912,
13,
18,
3
]
} | [
{
"id": "p_23",
"content": "Scopolamine Hydrobromide [SEP] An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics l",
"score": 1,
"type": null,
"tokenized_content": [
2,
25392,
10173,
25157,
329... |
{
"id": "q_24",
"content": "Hyoscine [SEP] e drug, in the treatment of the central effects of scopolamine (Hyoscine).",
"tokenized_content": [
2,
4527,
17413,
2912,
3,
47,
2838,
16,
1922,
1920,
2311,
1927,
1920,
4101,
2564,
1927,
25392,
10173,
25157,
12,
4527,
17413,
2912,
13,
18,
3
]
} | [
{
"id": "p_24",
"content": "Scopolamine Hydrobromide [SEP] An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics l",
"score": 1,
"type": null,
"tokenized_content": [
2,
25392,
10173,
25157,
329... |
{
"id": "q_25",
"content": "Galanthamine hydrobromide [SEP] Galanthamine hydrobromide, an anticholinesterase drug capable of penetrating the blood-br",
"tokenized_content": [
2,
5179,
7744,
3812,
3290,
18474,
16408,
1021,
3,
5179,
7744,
3812,
3290,
18474,
16408,
1021,
16,
1925,
5851,
12074,
21343,
2838,
7131,
1927,
19879,
1920,
2877,
17,
2387,
3
]
} | [
{
"id": "p_25",
"content": "Galantamine [SEP] A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor tha",
"score": 1,
"type": null,
"tokenized_content": [
2,
5179,
23200,
25157,
3,
43,
... |
{
"id": "q_26",
"content": "scopolamine [SEP] barrier, was used in a patient demonstrating central effects of scopolamine (hyoscine) overdosage. It is longer acting than physostigmine a",
"tokenized_content": [
2,
25392,
10173,
25157,
3,
7104,
16,
1982,
2251,
1922,
43,
2774,
7530,
4101,
2564,
1927,
25392,
10173,
25157,
12,
4527,
17413,
2912,
13,
17612,
5360,
2106,
18,
2176,
1977,
4872,
3
]
} | [
{
"id": "p_26",
"content": "Scopolamine Hydrobromide [SEP] An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics l",
"score": 1,
"type": null,
"tokenized_content": [
2,
25392,
10173,
25157,
329... |
{
"id": "q_27",
"content": "hyoscine [SEP] used in a patient demonstrating central effects of scopolamine (hyoscine) overdosage. It is longer acting than physostigmine and is used",
"tokenized_content": [
2,
4527,
17413,
2912,
3,
2251,
1922,
43,
2774,
7530,
4101,
2564,
1927,
25392,
10173,
25157,
12,
4527,
17413,
2912,
13,
17612,
5360,
2106,
18,
2176,
1977,
4872,
8290,
2254,
2861,
3
]
} | [
{
"id": "p_27",
"content": "Scopolamine Hydrobromide [SEP] An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics l",
"score": 1,
"type": null,
"tokenized_content": [
2,
25392,
10173,
25157,
329... |
{
"id": "q_28",
"content": "overdosage [SEP] patient demonstrating central effects of scopolamine (hyoscine) overdosage. It is longer acting than physostigmine and is used in anaesthe",
"tokenized_content": [
2,
17612,
5360,
2106,
3,
2774,
7530,
4101,
2564,
1927,
25392,
10173,
25157,
12,
4527,
17413,
2912,
13,
17612,
5360,
2106,
18,
2176,
1977,
4872,
8290,
2254,
2861,
2259,
29043,
2053,
3
]
} | [
{
"id": "p_28",
"content": "Drug Overdose [SEP] Accidental or deliberate use of a medication or street drug in excess of normal dosage.\n ",
"score": 1,
"type": null,
"tokenized_content": [
2,
2838,
21090,
3,
24842,
2014,
24921,
13108,
248... |
{
"id": "q_29",
"content": "physostigmine [SEP] of scopolamine (hyoscine) overdosage. It is longer acting than physostigmine and is used in anaesthesia to reverse the non-depolarizing neur",
"tokenized_content": [
2,
2861,
2259,
29043,
2053,
3,
1927,
25392,
10173,
25157,
12,
4527,
17413,
2912,
13,
17612,
5360,
2106,
18,
2176,
1977,
4872,
8290,
2254,
2861,
2259,
29043,
2053,
1930,
1977,
2251,
3
]
} | [
{
"id": "p_29",
"content": "Physostigmine [SEP] A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also c",
"score": 1,
"type": null,
"tokenized_content": [
2,
2861,
2259,
29043,
2053,
3,
... |
{
"id": "q_30",
"content": "lithium [SEP] Effects of uninephrectomy and high protein feeding on lithium-induced chronic renal failure in rats.",
"tokenized_content": [
2,
14330,
3,
2564,
1927,
22712,
2128,
6570,
5653,
1930,
2149,
2213,
6788,
1990,
14330,
17,
2719,
3724,
4604,
4574,
1922,
3615,
18,
3
]
} | [
{
"id": "p_30",
"content": "Lithium [SEP] An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of",
"score": 1,
"type": null,
"tokenized_content": [
2,
14330,
3,
1925,
6149,
1922,
1... |
{
"id": "q_31",
"content": "chronic renal failure [SEP] s of uninephrectomy and high protein feeding on lithium-induced chronic renal failure in rats.",
"tokenized_content": [
2,
3724,
4604,
4574,
3,
61,
1927,
22712,
2128,
6570,
5653,
1930,
2149,
2213,
6788,
1990,
14330,
17,
2719,
3724,
4604,
4574,
1922,
3615,
18,
3
]
} | [
{
"id": "p_31",
"content": "Kidney Failure, Chronic [SEP] The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the l",
"score": 1,
"type": null,
"tokenized_content": [
2,
5245,
4574,
16,
3724,
... |
{
"id": "q_32",
"content": "lithium [SEP] Rats with lithium-induced nephropathy were subjected to high protein (HP) feeding",
"tokenized_content": [
2,
14330,
3,
3615,
1956,
14330,
17,
2719,
15582,
1985,
6243,
1942,
2149,
2213,
12,
4688,
13,
6788,
3
]
} | [
{
"id": "p_32",
"content": "Lithium [SEP] An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of",
"score": 1,
"type": null,
"tokenized_content": [
2,
14330,
3,
1925,
6149,
1922,
1... |
{
"id": "q_33",
"content": "nephropathy [SEP] Rats with lithium-induced nephropathy were subjected to high protein (HP) feeding, uninephrectomy (NX",
"tokenized_content": [
2,
15582,
3,
3615,
1956,
14330,
17,
2719,
15582,
1985,
6243,
1942,
2149,
2213,
12,
4688,
13,
6788,
16,
22712,
2128,
6570,
5653,
12,
27578,
3
]
} | [
{
"id": "p_33",
"content": "Kidney Diseases [SEP] Pathological processes of the KIDNEY or its component tissues.\n ",
"score": 1,
"type": null,
"tokenized_content": [
2,
5245,
3902,
3,
6598,
4028,
1927,
1920,
5245,
2014,
2496,
... |
{
"id": "q_34",
"content": "renal failure [SEP] to induce glomerular hyperfiltration and further progression of renal failure. Newborn female Wistar rats were fed a lithium-containing diet ",
"tokenized_content": [
2,
4604,
4574,
3,
1942,
4769,
11655,
4194,
6870,
6003,
1930,
2520,
4380,
1927,
4604,
4574,
18,
12203,
4232,
15668,
3615,
1985,
5788,
43,
14330,
17,
3165,
3986,
3
]
} | [
{
"id": "p_34",
"content": "Renal Insufficiency [SEP] Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ",
"score": 1,
"type": null,
"tokenized_content": [
2,
4604,
14566,
3,
2961,
1... |
{
"id": "q_35",
"content": "Li [SEP] sed a fall in filtration fraction and an increase in fractional Li excretion. Lithium also caused proteinuria and systolic hyperte",
"tokenized_content": [
2,
2336,
3,
6276,
43,
6462,
1922,
10347,
3906,
1930,
1925,
2760,
1922,
14436,
2336,
11093,
18,
14330,
2222,
4189,
15831,
1930,
8541,
4506,
1021,
3
]
} | [
{
"id": "p_35",
"content": "Lithium [SEP] An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of",
"score": 1,
"type": null,
"tokenized_content": [
2,
14330,
3,
1925,
6149,
1922,
1... |
{
"id": "q_36",
"content": "Lithium [SEP] filtration fraction and an increase in fractional Li excretion. Lithium also caused proteinuria and systolic hypertension in absence of",
"tokenized_content": [
2,
14330,
3,
10347,
3906,
1930,
1925,
2760,
1922,
14436,
2336,
11093,
18,
14330,
2222,
4189,
15831,
1930,
8541,
5579,
1922,
3905,
1927,
3
]
} | [
{
"id": "p_36",
"content": "Lithium [SEP] An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of",
"score": 1,
"type": null,
"tokenized_content": [
2,
14330,
3,
1925,
6149,
1922,
1... |
{
"id": "q_37",
"content": "proteinuria [SEP] and an increase in fractional Li excretion. Lithium also caused proteinuria and systolic hypertension in absence of glomerulosclerosis. HP ",
"tokenized_content": [
2,
15831,
3,
1930,
1925,
2760,
1922,
14436,
2336,
11093,
18,
14330,
2222,
4189,
15831,
1930,
8541,
5579,
1922,
3905,
1927,
19268,
25081,
18,
4688,
3
]
} | [
{
"id": "p_37",
"content": "Proteinuria [SEP] The presence of proteins in the urine, an indicator of KIDNEY DISEASES.\n ",
"score": 1,
"type": null,
"tokenized_content": [
2,
15831,
3,
1920,
2990,
1927,
2697,
1922,
1920,
6960,
... |
{
"id": "q_38",
"content": "hypertension [SEP] onal Li excretion. Lithium also caused proteinuria and systolic hypertension in absence of glomerulosclerosis. HP failed to accentuante prog",
"tokenized_content": [
2,
5579,
3,
1990,
1923,
2336,
11093,
18,
14330,
2222,
4189,
15831,
1930,
8541,
5579,
1922,
3905,
1927,
19268,
25081,
18,
4688,
6617,
1942,
26884,
13785,
2057,
1965,
1029,
3
]
} | [
{
"id": "p_38",
"content": "Hypertension [SEP] Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is c",
"score": 1,
"type": null,
"tokenized_content": [
2,
5579,
3,
23334,
2149,
5510,
... |
{
"id": "q_39",
"content": "glomerulosclerosis [SEP] also caused proteinuria and systolic hypertension in absence of glomerulosclerosis. HP failed to accentuante progression of renal failure and in f",
"tokenized_content": [
2,
19268,
25081,
3,
2222,
4189,
15831,
1930,
8541,
5579,
1922,
3905,
1927,
19268,
25081,
18,
4688,
6617,
1942,
26884,
13785,
2057,
4380,
1927,
4604,
4574,
1930,
1922,
48,
3
]
} | [
{
"id": "p_39",
"content": "Glomerulonephritis [SEP] Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including anti",
"score": 1,
"type": null,
"tokenized_content": [
2,
27057,
3,
4531,
1927,
19... |
{
"id": "q_40",
"content": "creatinine [SEP] failure and in fact tended to increase GFR and decrease plasma creatinine levels in lithium pretreated rats. NX caused an additive deteri",
"tokenized_content": [
2,
9374,
3,
4574,
1930,
1922,
2371,
10587,
1942,
2760,
15316,
1930,
3714,
3582,
9374,
2428,
1922,
14330,
12152,
3615,
18,
27578,
4189,
1925,
10359,
10641,
1033,
3
]
} | [
{
"id": "p_40",
"content": "Creatinine [SEP] ",
"score": 1,
"type": null,
"tokenized_content": [
2,
9374,
3,
3
]
}
] |
{
"id": "q_41",
"content": "chronic renal failure [SEP] roteinuria and arterial systolic hypertension. In this model of chronic renal failure the decline in GFR is not accompanied by a corresponding fall i",
"tokenized_content": [
2,
3724,
4604,
4574,
3,
5337,
14818,
8754,
1930,
6624,
8541,
5579,
18,
1922,
2052,
2322,
1927,
3724,
4604,
4574,
1920,
6859,
1922,
15316,
1977,
2084,
7936,
2007,
43,
3980,
6462,
3
]
} | [
{
"id": "p_41",
"content": "Kidney Failure, Chronic [SEP] The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the l",
"score": 1,
"type": null,
"tokenized_content": [
2,
5245,
4574,
16,
3724,
... |
{
"id": "q_42",
"content": "Crohn's disease [SEP] Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive propert",
"tokenized_content": [
2,
17563,
11,
61,
2573,
3,
2311,
1927,
17563,
11,
61,
2573,
1956,
10630,
12546,
2687,
30,
1925,
7267,
1956,
12910,
3405,
1031,
3
]
} | [
{
"id": "p_42",
"content": "Crohn Disease [SEP] A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM",
"score": 1,
"type": null,
"tokenized_content": [
2,
17563,
2573,
3,
43,
3724,
... |
{
"id": "q_43",
"content": "fusidic acid [SEP] Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyc",
"tokenized_content": [
2,
10630,
12546,
2687,
3,
2311,
1927,
17563,
11,
61,
2573,
1956,
10630,
12546,
2687,
30,
1925,
7267,
1956,
12910,
3879,
2551,
1942,
21309,
3
]
} | [
{
"id": "p_43",
"content": "Fusidic Acid [SEP] An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting tra",
"score": 1,
"type": null,
"tokenized_content": [
2,
10630,
12546,
2687,
3,
1925,
... |
{
"id": "q_44",
"content": "cyclosporin [SEP] cid: an antibiotic with immunosuppressive properties similar to cyclosporin.",
"tokenized_content": [
2,
17640,
1921,
3,
18069,
30,
1925,
7267,
1956,
12910,
3879,
2551,
1942,
17640,
1921,
18,
3
]
} | [
{
"id": "p_44",
"content": "Cyclosporine [SEP] A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes.",
"score": 1,
"type": null,
"tokenized_content": [
2,
21002,
3,
43,
9821,
3075,
... |
{
"id": "q_45",
"content": "cyclosporin [SEP] h T-cell specific immunosuppressive effects similar to those of cyclosporin. Because of the need for the development of new treatments for ",
"tokenized_content": [
2,
17640,
1921,
3,
50,
62,
17,
2024,
2487,
12910,
2564,
2551,
1942,
2690,
1927,
17640,
1921,
18,
2882,
1927,
1920,
2942,
1958,
1920,
2740,
1927,
2814,
4930,
1958,
3
]
} | [
{
"id": "p_45",
"content": "Cyclosporine [SEP] A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes.",
"score": 1,
"type": null,
"tokenized_content": [
2,
21002,
3,
43,
9821,
3075,
... |
{
"id": "q_46",
"content": "Crohn's disease [SEP] . Because of the need for the development of new treatments for Crohn's disease, a pilot study was undertaken to estimate the pharmacodynamics ",
"tokenized_content": [
2,
17563,
11,
61,
2573,
3,
18,
2882,
1927,
1920,
2942,
1958,
1920,
2740,
1927,
2814,
4930,
1958,
17563,
11,
61,
2573,
16,
43,
9404,
2161,
1982,
10466,
1942,
5383,
1920,
3
]
} | [
{
"id": "p_46",
"content": "Crohn Disease [SEP] A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM",
"score": 1,
"type": null,
"tokenized_content": [
2,
17563,
2573,
3,
43,
3724,
... |
{
"id": "q_47",
"content": "fusidic acid [SEP] undertaken to estimate the pharmacodynamics and tolerability of fusidic acid treatment in chronic active, therapy-resistant patients. Eight ",
"tokenized_content": [
2,
10630,
12546,
2687,
3,
10466,
1942,
5383,
1920,
24358,
1036,
1930,
17934,
1927,
10630,
12546,
2687,
2311,
1922,
3724,
3500,
16,
3181,
17,
4910,
2132,
18,
5066,
3
]
} | [
{
"id": "p_47",
"content": "Fusidic Acid [SEP] An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting tra",
"score": 1,
"type": null,
"tokenized_content": [
2,
10630,
12546,
2687,
3,
1925,
... |
{
"id": "q_48",
"content": "Fusidic acid [SEP] Fusidic acid is an antibiotic with T-cell specific immunosuppressive effects",
"tokenized_content": [
2,
10630,
12546,
2687,
3,
10630,
12546,
2687,
1977,
1925,
7267,
1956,
62,
17,
2024,
2487,
12910,
2564,
3
]
} | [
{
"id": "p_48",
"content": "Fusidic Acid [SEP] An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting tra",
"score": 1,
"type": null,
"tokenized_content": [
2,
10630,
12546,
2687,
3,
1925,
... |
{
"id": "q_49",
"content": "nausea [SEP] cts, but dose reduction was required in two patients because of nausea. Biochemically, an increase in alkaline phosphatases was noted ",
"tokenized_content": [
2,
13759,
3,
15359,
16,
2308,
3253,
3378,
1982,
3414,
1922,
2288,
2132,
2882,
1927,
13759,
18,
25839,
16,
1925,
2760,
1922,
10746,
19131,
1982,
5040,
3
]
} | [
{
"id": "p_49",
"content": "Nausea [SEP] An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and moti",
"score": 1,
"type": null,
"tokenized_content": [
2,
13759,
3,
1925,
25429,
15826,
... |
{
"id": "q_50",
"content": "inflammatory bowel disease [SEP] rationale for the use of fusidic acid at the cytokine level in inflammatory bowel disease, we suggest that the role of this treatment should be further i",
"tokenized_content": [
2,
3769,
9472,
2573,
3,
13202,
1958,
1920,
2485,
1927,
10630,
12546,
2687,
2019,
1920,
6137,
2237,
1922,
3769,
9472,
2573,
16,
2038,
3220,
1988,
1920,
2770,
1927,
2052,
2311,
3066,
3
]
} | [
{
"id": "p_50",
"content": "Inflammatory Bowel Diseases [SEP] Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes C",
"score": 1,
"type": null,
"tokenized_content": [
2,
3769,
9472,
3902,
3,
... |
{
"id": "q_51",
"content": "myocardial injury [SEP] Electrocardiographic evidence of myocardial injury in psychiatrically hospitalized cocaine abusers.",
"tokenized_content": [
2,
6497,
4047,
3,
15894,
4158,
3095,
1927,
6497,
4047,
1922,
7652,
2169,
13123,
9045,
7764,
5675,
18,
3
]
} | [
{
"id": "p_51",
"content": "Cardiomyopathies [SEP] A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classifi",
"score": 1,
"type": null,
"tokenized_content": [
2,
8291,
16038,
3,
43,
2210,
... |
{
"id": "q_52",
"content": "cocaine [SEP] c evidence of myocardial injury in psychiatrically hospitalized cocaine abusers.",
"tokenized_content": [
2,
9045,
3,
45,
3095,
1927,
6497,
4047,
1922,
7652,
2169,
13123,
9045,
7764,
5675,
18,
3
]
} | [
{
"id": "p_52",
"content": "Cocaine [SEP] An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinic",
"score": 1,
"type": null,
"tokenized_content": [
2,
9045,
3,
1925,
29951,
9603,
5... |
{
"id": "q_53",
"content": "cocaine [SEP] The electrocardiograms (ECG) of 99 cocaine-abusing patients were compared with the ECGs of 50 schizophreni",
"tokenized_content": [
2,
9045,
3,
1920,
22477,
1036,
12,
11497,
13,
1927,
4922,
9045,
17,
2186,
16435,
2132,
1985,
2452,
1956,
1920,
11497,
1036,
1927,
2761,
7603,
1033,
3
]
} | [
{
"id": "p_53",
"content": "Cocaine [SEP] An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinic",
"score": 1,
"type": null,
"tokenized_content": [
2,
9045,
3,
1925,
29951,
9603,
5... |
{
"id": "q_54",
"content": "schizophrenic [SEP] f 99 cocaine-abusing patients were compared with the ECGs of 50 schizophrenic controls. Eleven of the cocaine abusers and none of the control",
"tokenized_content": [
2,
28247,
3,
48,
4922,
9045,
17,
2186,
16435,
2132,
1985,
2452,
1956,
1920,
11497,
1036,
1927,
2761,
28247,
3562,
18,
14483,
1927,
1920,
9045,
7764,
5675,
1930,
6046,
1927,
1920,
3
]
} | [
{
"id": "p_54",
"content": "Schizophrenia [SEP] A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALL",
"score": 1,
"type": null,
"tokenized_content": [
2,
7899,
3,
43,
4010,
6687,
... |
{
"id": "q_55",
"content": "myocardial injury [SEP] busers and none of the controls had ECG evidence of significant myocardial injury defined as myocardial infarction, ischemia, and bundle branch b",
"tokenized_content": [
2,
6497,
4047,
3,
11730,
2045,
1930,
6046,
1927,
1920,
3562,
2430,
11497,
3095,
1927,
2228,
6497,
4047,
3608,
1966,
6497,
8358,
16,
7716,
16,
1930,
14142,
6089,
44,
3
]
} | [
{
"id": "p_55",
"content": "Cardiomyopathies [SEP] A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classifi",
"score": 1,
"type": null,
"tokenized_content": [
2,
8291,
16038,
3,
43,
2210,
... |
{
"id": "q_56",
"content": "myocardial infarction [SEP] ls had ECG evidence of significant myocardial injury defined as myocardial infarction, ischemia, and bundle branch block.",
"tokenized_content": [
2,
6497,
8358,
3,
6639,
2430,
11497,
3095,
1927,
2228,
6497,
4047,
3608,
1966,
6497,
8358,
16,
7716,
16,
1930,
14142,
6089,
3367,
18,
3
]
} | [
{
"id": "p_56",
"content": "Myocardial Infarction [SEP] NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).\n ",
"score": 1,
"type": null,
"tokenized_content": [
2,
6497,
8358,
3,
7476,
1927,
19... |
{
"id": "q_57",
"content": "ischemia [SEP] significant myocardial injury defined as myocardial infarction, ischemia, and bundle branch block.",
"tokenized_content": [
2,
7716,
3,
2228,
6497,
4047,
3608,
1966,
6497,
8358,
16,
7716,
16,
1930,
14142,
6089,
3367,
18,
3
]
} | [
{
"id": "p_57",
"content": "Ischemia [SEP] A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS,",
"score": 1,
"type": null,
"tokenized_content": [
2,
7716,
3,
43,
26497,
1915,
90... |
{
"id": "q_58",
"content": "bundle branch block [SEP] ocardial injury defined as myocardial infarction, ischemia, and bundle branch block.",
"tokenized_content": [
2,
14142,
6089,
3367,
3,
5084,
15152,
4047,
3608,
1966,
6497,
8358,
16,
7716,
16,
1930,
14142,
6089,
3367,
18,
3
]
} | [
{
"id": "p_58",
"content": "Bundle-Branch Block [SEP] A form of heart block in which the electrical stimulation of HEART VENTRICLES is interrupted at either one of the branches of BU",
"score": 1,
"type": null,
"tokenized_content": [
2,
14142,
17,
6089,
3367,
... |
{
"id": "q_59",
"content": "Sulpiride [SEP] Sulpiride-induced tardive dystonia.",
"tokenized_content": [
2,
9596,
10984,
20332,
1021,
3,
9596,
10984,
20332,
1021,
17,
2719,
14517,
7408,
1961,
23357,
18,
3
]
} | [
{
"id": "p_59",
"content": "Sulpiride [SEP] A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid.",
"score": 1,
"type": null,
"tokenized_content": [
2,
9596,
10984,
20332,
1021,
3,
... |
{
"id": "q_60",
"content": "tardive dystonia [SEP] Sulpiride-induced tardive dystonia.",
"tokenized_content": [
2,
14517,
7408,
1961,
23357,
3,
9596,
10984,
20332,
1021,
17,
2719,
14517,
7408,
1961,
23357,
18,
3
]
} | [
{
"id": "p_60",
"content": "Dystonia [SEP] An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often aff",
"score": 1,
"type": null,
"tokenized_content": [
2,
23357,
3,
1925,
14204,
2014,
... |
{
"id": "q_61",
"content": "Sulpiride [SEP] Sulpiride is a selective D2-receptor antagonist with antipsychotic and an",
"tokenized_content": [
2,
9596,
10984,
20332,
1021,
3,
9596,
10984,
20332,
1021,
1977,
43,
5328,
8631,
17,
3148,
8151,
1956,
17581,
1930,
1925,
3
]
} | [
{
"id": "p_61",
"content": "Sulpiride [SEP] A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid.",
"score": 1,
"type": null,
"tokenized_content": [
2,
9596,
10984,
20332,
1021,
3,
... |
{
"id": "q_62",
"content": "antidepressant [SEP] de is a selective D2-receptor antagonist with antipsychotic and antidepressant properties. Although initially thought to be free of extrapyram",
"tokenized_content": [
2,
14183,
3,
2028,
1977,
43,
5328,
8631,
17,
3148,
8151,
1956,
17581,
1930,
14183,
3879,
18,
2876,
6370,
6212,
1942,
1998,
3294,
1927,
21346,
3553,
1976,
3
]
} | [
{
"id": "p_62",
"content": "Antidepressive Agents [SEP] Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE ",
"score": 1,
"type": null,
"tokenized_content": [
2,
11248,
2320,
4820,
3,
... |
{
"id": "q_63",
"content": "sulpiride [SEP] gh initially thought to be free of extrapyramidal side effects, sulpiride-induced tardive dyskinesia and parkinsonism have been reported ",
"tokenized_content": [
2,
9596,
10984,
20332,
1021,
3,
6101,
6370,
6212,
1942,
1998,
3294,
1927,
21346,
3553,
25238,
1923,
4159,
2564,
16,
9596,
10984,
20332,
1021,
17,
2719,
14517,
7408,
1961,
3890,
26682,
3
]
} | [
{
"id": "p_63",
"content": "Sulpiride [SEP] A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid.",
"score": 1,
"type": null,
"tokenized_content": [
2,
9596,
10984,
20332,
1021,
3,
... |
{
"id": "q_64",
"content": "tardive dyskinesia [SEP] ht to be free of extrapyramidal side effects, sulpiride-induced tardive dyskinesia and parkinsonism have been reported occasionally. We studied a ",
"tokenized_content": [
2,
14517,
7408,
1961,
3890,
26682,
3,
5334,
1942,
1998,
3294,
1927,
21346,
3553,
25238,
1923,
4159,
2564,
16,
9596,
10984,
20332,
1021,
17,
2719,
14517,
7408,
1961,
3890,
26682,
1930,
3
]
} | [
{
"id": "p_64",
"content": "Dyskinesia, Drug-Induced [SEP] Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or",
"score": 1,
"type": null,
"tokenized_content": [
2,
3890,
26682,
16,
2838,
... |
{
"id": "q_65",
"content": "parkinsonism [SEP] yramidal side effects, sulpiride-induced tardive dyskinesia and parkinsonism have been reported occasionally. We studied a 37-year-old man w",
"tokenized_content": [
2,
26214,
3,
13031,
25238,
1923,
4159,
2564,
16,
9596,
10984,
20332,
1021,
17,
2719,
14517,
7408,
1961,
3890,
26682,
1930,
26214,
2162,
2252,
2568,
14647,
18,
2038,
3942,
43,
3191,
3
]
} | [
{
"id": "p_65",
"content": "Parkinson Disease, Secondary [SEP] Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected co",
"score": 1,
"type": null,
"tokenized_content": [
2,
10124,
2573,
16,
406... |
{
"id": "q_66",
"content": "dystonia [SEP] We studied a 37-year-old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy. We could not ",
"tokenized_content": [
2,
23357,
3,
2038,
3942,
43,
3191,
17,
2476,
17,
4156,
2323,
2746,
3530,
7733,
16294,
23357,
2651,
22,
3221,
2256,
6801,
9596,
10984,
20332,
1021,
3181,
18,
2038,
2578,
2084,
3
]
} | [
{
"id": "p_66",
"content": "Dystonia [SEP] An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often aff",
"score": 1,
"type": null,
"tokenized_content": [
2,
23357,
3,
1925,
14204,
2014,
... |
{
"id": "q_67",
"content": "tardive dystonia [SEP] py. We could not find any previous reports of sulpiride-induced tardive dystonia.",
"tokenized_content": [
2,
14517,
7408,
1961,
23357,
3,
6085,
18,
2038,
2578,
2084,
5387,
2967,
2555,
4710,
1927,
9596,
10984,
20332,
1021,
17,
2719,
14517,
7408,
1961,
23357,
18,
3
]
} | [
{
"id": "p_67",
"content": "Dystonia [SEP] An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often aff",
"score": 1,
"type": null,
"tokenized_content": [
2,
23357,
3,
1925,
14204,
2014,
... |
{
"id": "q_68",
"content": "auditory toxicity [SEP] Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine.",
"tokenized_content": [
2,
8401,
5532,
3,
10046,
1930,
8401,
5532,
1922,
3243,
13968,
1954,
6756,
2132,
5962,
2270,
2070,
19481,
11414,
25157,
18,
3
]
} | [
{
"id": "p_68",
"content": "Hearing Disorders [SEP] Conditions that impair the transmission of auditory impulses and information from the level of the ear to the temporal cortices,",
"score": 1,
"type": null,
"tokenized_content": [
2,
8512,
4414,
3,
2961,
1988... |
{
"id": "q_69",
"content": "desferrioxamine [SEP] Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine.",
"tokenized_content": [
2,
2270,
2070,
19481,
11414,
25157,
3,
10046,
1930,
8401,
5532,
1922,
3243,
13968,
1954,
6756,
2132,
5962,
2270,
2070,
19481,
11414,
25157,
18,
3
]
} | [
{
"id": "p_69",
"content": "Deferoxamine [SEP] Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in th",
"score": 1,
"type": null,
"tokenized_content": [
2,
20519,
2325,
3812,
3,
4613,
... |
{
"id": "q_70",
"content": "desferrioxamine [SEP] an 18-month period of study 41 hemodialyzed patients receiving desferrioxamine (10-40 mg/kg BW/3 times weekly) for the first time were monitor",
"tokenized_content": [
2,
2270,
2070,
19481,
11414,
25157,
3,
1925,
2654,
17,
2935,
3047,
1927,
2161,
4353,
3243,
13968,
1954,
6756,
2132,
5962,
2270,
2070,
19481,
11414,
25157,
12,
2119,
17,
3040,
2786,
3
]
} | [
{
"id": "p_70",
"content": "Deferoxamine [SEP] Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in th",
"score": 1,
"type": null,
"tokenized_content": [
2,
20519,
2325,
3812,
3,
4613,
... |
{
"id": "q_71",
"content": "auditory toxicity [SEP] l toxicity. 6 patients presented clinical symptoms of visual or auditory toxicity. Moreover, detailed ophthalmologic and audiologic studies discl",
"tokenized_content": [
2,
8401,
5532,
3,
54,
5532,
18,
26,
2132,
3549,
2535,
3601,
1927,
3737,
2014,
8401,
5532,
18,
3950,
16,
5720,
14554,
4467,
1930,
18609,
22284,
1935,
2351,
8973,
3
]
} | [
{
"id": "p_71",
"content": "Hearing Disorders [SEP] Conditions that impair the transmission of auditory impulses and information from the level of the ear to the temporal cortices,",
"score": 1,
"type": null,
"tokenized_content": [
2,
8512,
4414,
3,
2961,
1988... |
{
"id": "q_72",
"content": "Visual toxicity [SEP] tudies disclosed abnormalities in 7 more asymptomatic patients. Visual toxicity was of retinal origin and was characterized by a tritan-type dy",
"tokenized_content": [
2,
3737,
5532,
3,
9037,
7408,
1918,
20485,
6754,
1922,
27,
2253,
9978,
2132,
18,
3737,
5532,
1982,
1927,
6943,
4853,
1930,
1982,
4378,
2007,
43,
5083,
3285,
17,
2601,
6433,
3
]
} | [
{
"id": "p_72",
"content": "Vision Disorders [SEP] Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peri",
"score": 1,
"type": null,
"tokenized_content": [
2,
9266,
4414,
3,
3737,
12454... |
{
"id": "q_73",
"content": "a loss of visual acuity [SEP] ized by a tritan-type dyschromatopsy, sometimes associated with a loss of visual acuity and pigmentary retinal deposits. Auditory toxicity was characte",
"tokenized_content": [
2,
43,
3257,
1927,
3737,
12320,
3,
25455,
1919,
2007,
43,
5083,
3285,
17,
2601,
3890,
2072,
2018,
8286,
9196,
16,
8929,
2458,
1956,
43,
3257,
1927,
3737,
12320,
1930,
12905,
3
]
} | [
{
"id": "p_73",
"content": "Vision Disorders [SEP] Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peri",
"score": 1,
"type": null,
"tokenized_content": [
2,
9266,
4414,
3,
3737,
12454... |
{
"id": "q_74",
"content": "pigmentary retinal deposits [SEP] omatopsy, sometimes associated with a loss of visual acuity and pigmentary retinal deposits. Auditory toxicity was characterized by a mid- to high-frequenc",
"tokenized_content": [
2,
12905,
2141,
6943,
14371,
3,
7254,
8286,
9196,
16,
8929,
2458,
1956,
43,
3257,
1927,
3737,
12320,
1930,
12905,
2141,
6943,
14371,
18,
8401,
5532,
1982,
4378,
2007,
43,
3953,
3
]
} | [
{
"id": "p_74",
"content": "Retinal Diseases [SEP] ",
"score": 1,
"type": null,
"tokenized_content": [
2,
6943,
3902,
3,
3
]
}
] |
{
"id": "q_75",
"content": "Auditory toxicity [SEP] d with a loss of visual acuity and pigmentary retinal deposits. Auditory toxicity was characterized by a mid- to high-frequency neurosensorial he",
"tokenized_content": [
2,
8401,
5532,
3,
46,
1956,
43,
3257,
1927,
3737,
12320,
1930,
12905,
2141,
6943,
14371,
18,
8401,
5532,
1982,
4378,
2007,
43,
3953,
17,
1942,
2149,
17,
3528,
7318,
13433,
3
]
} | [
{
"id": "p_75",
"content": "Hearing Disorders [SEP] Conditions that impair the transmission of auditory impulses and information from the level of the ear to the temporal cortices,",
"score": 1,
"type": null,
"tokenized_content": [
2,
8512,
4414,
3,
2961,
1988... |
{
"id": "q_76",
"content": "neurosensorial hearing loss [SEP] Auditory toxicity was characterized by a mid- to high-frequency neurosensorial hearing loss and the lesion was of the cochlear type. Desferrioxamine withdr",
"tokenized_content": [
2,
7318,
13433,
2086,
8512,
3257,
3,
8401,
5532,
1982,
4378,
2007,
43,
3953,
17,
1942,
2149,
17,
3528,
7318,
13433,
2086,
8512,
3257,
1930,
1920,
5709,
1982,
1927,
1920,
15865,
3
]
} | [
{
"id": "p_76",
"content": "Hearing Loss, Sensorineural [SEP] Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round ",
"score": 1,
"type": null,
"tokenized_content": [
2,
8512,
3257,
16,
6443,... |
{
"id": "q_77",
"content": "Desferrioxamine [SEP] sensorial hearing loss and the lesion was of the cochlear type. Desferrioxamine withdrawal resulted in a complete recovery of visual function i",
"tokenized_content": [
2,
2270,
2070,
19481,
11414,
25157,
3,
6443,
2086,
8512,
3257,
1930,
1920,
5709,
1982,
1927,
1920,
15865,
2601,
18,
2270,
2070,
19481,
11414,
25157,
9594,
4306,
1922,
43,
4080,
5241,
3
]
} | [
{
"id": "p_77",
"content": "Deferoxamine [SEP] Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in th",
"score": 1,
"type": null,
"tokenized_content": [
2,
20519,
2325,
3812,
3,
4613,
... |
{
"id": "q_78",
"content": "hearing loss [SEP] ty was characterized by a mid- to high-frequency neurosensorial hearing loss and the lesion was of the cochlear type. Desferrioxamine withdr",
"tokenized_content": [
2,
8512,
3257,
3,
6227,
1982,
4378,
2007,
43,
3953,
17,
1942,
2149,
17,
3528,
7318,
13433,
2086,
8512,
3257,
1930,
1920,
5709,
1982,
1927,
1920,
15865,
2601,
18,
2270,
2070,
3
]
} | [
{
"id": "p_78",
"content": "Hearing Loss [SEP] A general term for the complete or partial loss of the ability to hear from one or both ears.\n ",
"score": 1,
"type": null,
"tokenized_content": [
2,
8512,
3257,
3,
43,
3335,
2576,
1958,
1920... |
{
"id": "q_79",
"content": "toxicity [SEP] for the first time were monitored for detection of audiovisual toxicity. 6 patients presented clinical symptoms of visual or auditory t",
"tokenized_content": [
2,
5532,
3,
1958,
1920,
2561,
2367,
1985,
7027,
1958,
3805,
1927,
18609,
7400,
2224,
5532,
18,
26,
2132,
3549,
2535,
3601,
1927,
3737,
2014,
8401,
62,
3
]
} | [
{
"id": "p_79",
"content": "Drug-Related Side Effects and Adverse Reactions [SEP] Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chem",
"score": 1,
"type": null,
"tokenized_content": [
2,
2838,
17,
... |
{
"id": "q_80",
"content": "Myasthenia gravis [SEP] Myasthenia gravis presenting as weakness after magnesium administration.",
"tokenized_content": [
2,
3057,
27618,
8572,
12413,
1937,
3,
3057,
27618,
8572,
12413,
1937,
8326,
1966,
12175,
2256,
13148,
4183,
18,
3
]
} | [
{
"id": "p_80",
"content": "Myasthenia Gravis [SEP] A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed agai",
"score": 1,
"type": null,
"tokenized_content": [
2,
3057,
27618,
8572,
12413,
... |
{
"id": "q_81",
"content": "magnesium [SEP] Myasthenia gravis presenting as weakness after magnesium administration.",
"tokenized_content": [
2,
13148,
3,
3057,
27618,
8572,
12413,
1937,
8326,
1966,
12175,
2256,
13148,
4183,
18,
3
]
} | [
{
"id": "p_81",
"content": "Magnesium [SEP] A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of",
"score": 1,
"type": null,
"tokenized_content": [
2,
13148,
3,
43,
16790,
6149,
... |
{
"id": "q_82",
"content": "neuromuscular disease [SEP] We studied a patient with no prior history of neuromuscular disease who became virtually quadriplegic after parenteral magnesium ad",
"tokenized_content": [
2,
15829,
2573,
3,
2038,
3942,
43,
2774,
1956,
2239,
3432,
4403,
1927,
15829,
2573,
2746,
7935,
13224,
10264,
13229,
6541,
1935,
2256,
20301,
13148,
2041,
3
]
} | [
{
"id": "p_82",
"content": "Neuromuscular Diseases [SEP] A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manif",
"score": 1,
"type": null,
"tokenized_content": [
2,
15829,
3902,
3,
43,
... |
{
"id": "q_83",
"content": "quadriplegic [SEP] no prior history of neuromuscular disease who became virtually quadriplegic after parenteral magnesium administration for preeclampsia. The",
"tokenized_content": [
2,
10264,
13229,
6541,
1935,
3,
2239,
3432,
4403,
1927,
15829,
2573,
2746,
7935,
13224,
10264,
13229,
6541,
1935,
2256,
20301,
13148,
4183,
1958,
17494,
18,
1920,
3
]
} | [
{
"id": "p_83",
"content": "Quadriplegia [SEP] Severe or complete loss of motor function in all four limbs which may result from BRAIN DISEASES; SPINAL CORD DISEASES; PERIPHER",
"score": 1,
"type": null,
"tokenized_content": [
2,
10264,
13229,
6541,
2126,
3,
... |
{
"id": "q_84",
"content": "magnesium [SEP] ular disease who became virtually quadriplegic after parenteral magnesium administration for preeclampsia. The serum magnesium concentrat",
"tokenized_content": [
2,
13148,
3,
3570,
1933,
2573,
2746,
7935,
13224,
10264,
13229,
6541,
1935,
2256,
20301,
13148,
4183,
1958,
17494,
18,
1920,
3256,
13148,
2587,
1926,
3
]
} | [
{
"id": "p_84",
"content": "Magnesium [SEP] A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of",
"score": 1,
"type": null,
"tokenized_content": [
2,
13148,
3,
43,
16790,
6149,
... |
{
"id": "q_85",
"content": "preeclampsia [SEP] ally quadriplegic after parenteral magnesium administration for preeclampsia. The serum magnesium concentration was 3.0 mEq/L, which is usua",
"tokenized_content": [
2,
17494,
3,
2136,
1012,
10264,
13229,
6541,
1935,
2256,
20301,
13148,
4183,
1958,
17494,
18,
1920,
3256,
13148,
3110,
1982,
23,
18,
20,
25509,
19,
54,
16,
2154,
1977,
2022,
3
]
} | [
{
"id": "p_85",
"content": "Pre-Eclampsia [SEP] A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or with",
"score": 1,
"type": null,
"tokenized_content": [
2,
2097,
17,
24938,
3,
43,
... |
{
"id": "q_86",
"content": "postsynaptic neuromuscular blockade [SEP] icant facilitation at rapid rates or after exercise, suggesting postsynaptic neuromuscular blockade. After her strength returned, repetitive stimulation was normal",
"tokenized_content": [
2,
13090,
15829,
9847,
3,
14784,
4905,
17477,
2019,
4052,
3389,
2014,
2256,
4975,
16,
3783,
13090,
15829,
9847,
18,
2256,
3656,
4568,
10418,
16,
12089,
4177,
1982,
2791,
3
]
} | [
{
"id": "p_86",
"content": "Neuromuscular Diseases [SEP] A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manif",
"score": 1,
"type": null,
"tokenized_content": [
2,
15829,
3902,
3,
43,
... |
{
"id": "q_87",
"content": "acetylcholine [SEP] ut single fiber EMG revealed increased jitter and blocking. Her acetylcholine receptor antibody level was markedly elevated. Although paralys",
"tokenized_content": [
2,
14561,
3,
11112,
2957,
6832,
13952,
3404,
2502,
14280,
3519,
1915,
1930,
7472,
18,
3656,
14561,
3148,
3533,
2237,
1982,
7686,
4664,
18,
2876,
11271,
2012,
3
]
} | [
{
"id": "p_87",
"content": "Acetylcholine [SEP] A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathe",
"score": 1,
"type": null,
"tokenized_content": [
2,
14561,
3,
43,
15223,
2435,
... |
{
"id": "q_88",
"content": "paralysis [SEP] choline receptor antibody level was markedly elevated. Although paralysis after magnesium administration has been described in patients w",
"tokenized_content": [
2,
18973,
3,
15440,
3148,
3533,
2237,
1982,
7686,
4664,
18,
2876,
18973,
2256,
13148,
4183,
2258,
2252,
2910,
1922,
2132,
65,
3
]
} | [
{
"id": "p_88",
"content": "Paralysis [SEP] A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level",
"score": 1,
"type": null,
"tokenized_content": [
2,
18973,
3,
43,
3335,
2576,
2... |
{
"id": "q_89",
"content": "myasthenia gravis [SEP] nesium administration has been described in patients with known myasthenia gravis, it has not previously been reported to be the initial or only ",
"tokenized_content": [
2,
3057,
27618,
8572,
12413,
1937,
3,
12100,
2457,
4183,
2258,
2252,
2910,
1922,
2132,
1956,
3171,
3057,
27618,
8572,
12413,
1937,
16,
2176,
2258,
2084,
3024,
2252,
2568,
1942,
1998,
3
]
} | [
{
"id": "p_89",
"content": "Myasthenia Gravis [SEP] A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed agai",
"score": 1,
"type": null,
"tokenized_content": [
2,
3057,
27618,
8572,
12413,
... |
{
"id": "q_90",
"content": "disorder of neuromuscular transmission [SEP] ffects of magnesium should be suspected of having an underlying disorder of neuromuscular transmission.",
"tokenized_content": [
2,
4770,
1927,
15829,
5303,
3,
10735,
2284,
1927,
13148,
3066,
1998,
9407,
1927,
4537,
1925,
5030,
4770,
1927,
15829,
5303,
18,
3
]
} | [
{
"id": "p_90",
"content": "Neuromuscular Junction Diseases [SEP] Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that",
"score": 1,
"type": null,
"tokenized_content": [
2,
15829,
6910,
3902,
... |
{
"id": "q_91",
"content": "Chloroacetaldehyde [SEP] Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclo",
"tokenized_content": [
2,
10107,
7681,
8790,
3,
10107,
7681,
8790,
1930,
2496,
5100,
1942,
14984,
4575,
18068,
3349,
3145,
2409,
2311,
1956,
17009,
3
]
} | [
{
"id": "p_91",
"content": "chloroacetaldehyde [SEP] ",
"score": 1,
"type": null,
"tokenized_content": [
2,
10107,
7681,
8790,
3,
3
]
}
] |
{
"id": "q_92",
"content": "cyclophosphamide [SEP] ehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.",
"tokenized_content": [
2,
17135,
3,
12429,
2584,
1021,
1930,
2496,
5100,
1942,
14984,
4575,
18068,
3349,
3145,
2409,
2311,
1956,
17135,
2014,
2647,
1951,
6016,
16408,
1021,
18,
1925,
3599,
2161,
19,
3662,
3
]
} | [
{
"id": "p_92",
"content": "Cyclophosphamide [SEP] Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to fo",
"score": 1,
"type": null,
"tokenized_content": [
2,
17135,
3,
7897,
1927,
1925... |
{
"id": "q_93",
"content": "ifosfamide [SEP] bution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.",
"tokenized_content": [
2,
2647,
1951,
6016,
16408,
1021,
3,
2308,
2001,
1942,
14984,
4575,
18068,
3349,
3145,
2409,
2311,
1956,
17135,
2014,
2647,
1951,
6016,
16408,
1021,
18,
1925,
3599,
2161,
19,
3662,
3
]
} | [
{
"id": "p_93",
"content": "Ifosfamide [SEP] Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent.\n ",
"score": 1,
"type": null,
"tokenized_content": [
2,
2647,
1951,
6016,
16408,
1021,
3,
... |
{
"id": "q_94",
"content": "chloroacetaldehyde [SEP] Based on clinical data, indicating that chloroacetaldehyde (CAA) is an important metabolite of oxazaphosphorine cytostatic",
"tokenized_content": [
2,
10107,
7681,
8790,
3,
2454,
1990,
2535,
2230,
16,
4168,
1988,
10107,
7681,
8790,
12,
20951,
13,
1977,
1925,
2715,
9483,
1927,
28905,
12813,
10614,
2053,
5521,
3857,
2002,
3
]
} | [
{
"id": "p_94",
"content": "chloroacetaldehyde [SEP] ",
"score": 1,
"type": null,
"tokenized_content": [
2,
10107,
7681,
8790,
3,
3
]
}
] |
{
"id": "q_95",
"content": "CAA [SEP] Based on clinical data, indicating that chloroacetaldehyde (CAA) is an important metabolite of oxazaphosphorine cytostatics, an",
"tokenized_content": [
2,
20951,
3,
2454,
1990,
2535,
2230,
16,
4168,
1988,
10107,
7681,
8790,
12,
20951,
13,
1977,
1925,
2715,
9483,
1927,
28905,
12813,
10614,
2053,
5521,
3857,
2837,
16,
1925,
3
]
} | [
{
"id": "p_95",
"content": "chloroacetaldehyde [SEP] ",
"score": 1,
"type": null,
"tokenized_content": [
2,
10107,
7681,
8790,
3,
3
]
}
] |
{
"id": "q_96",
"content": "hemorrhagic [SEP] out in order to elucidate the role of CAA in the development of hemorrhagic cystitis. The data demonstrate that CAA after i.v. administrati",
"tokenized_content": [
2,
16052,
3,
2397,
1922,
3238,
1942,
9970,
1920,
2770,
1927,
20951,
1922,
1920,
2740,
1927,
16052,
9446,
3678,
18,
1920,
2230,
4504,
1988,
20951,
2256,
51,
18,
64,
18,
10473,
3
]
} | [
{
"id": "p_96",
"content": "Hemorrhage [SEP] Bleeding or escape of blood from a vessel.\n ",
"score": 1,
"type": null,
"tokenized_content": [
2,
10489,
3,
7633,
2014,
11781,
1927,
2877,
2037,
43,
8072,
18,
3
]
... |
{
"id": "q_97",
"content": "cystitis [SEP] to elucidate the role of CAA in the development of hemorrhagic cystitis. The data demonstrate that CAA after i.v. administration does n",
"tokenized_content": [
2,
9446,
3678,
3,
1942,
9970,
1920,
2770,
1927,
20951,
1922,
1920,
2740,
1927,
16052,
9446,
3678,
18,
1920,
2230,
4504,
1988,
20951,
2256,
51,
18,
64,
18,
4183,
3731,
56,
3
]
} | [
{
"id": "p_97",
"content": "Cystitis [SEP] Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful ",
"score": 1,
"type": null,
"tokenized_content": [
2,
9446,
3678,
3,
4531,
1927,
1... |
{
"id": "q_98",
"content": "bladder damage [SEP] trate that CAA after i.v. administration does not contribute to bladder damage. When instilled directly into the bladder, CAA exerts urotoxic ",
"tokenized_content": [
2,
7821,
4293,
3,
3390,
2057,
1988,
20951,
2256,
51,
18,
64,
18,
4183,
3731,
2084,
4672,
1942,
7821,
4293,
18,
2469,
4766,
6297,
4103,
2460,
1920,
7821,
16,
20951,
14235,
3
]
} | [
{
"id": "p_98",
"content": "Urinary Bladder Diseases [SEP] Pathological processes of the URINARY BLADDER.\n ",
"score": 1,
"type": null,
"tokenized_content": [
2,
7075,
7821,
3902,
3,
6598,
4028,
1927,
1920,
7075,
7821,
1... |
{
"id": "q_99",
"content": "mesna [SEP] xic effects, it is, however, susceptible to detoxification with mesna.",
"tokenized_content": [
2,
4438,
2175,
3,
11551,
1030,
2564,
16,
2176,
1977,
16,
2406,
16,
7819,
1942,
18169,
1956,
4438,
2175,
18,
3
]
} | [
{
"id": "p_99",
"content": "Mesna [SEP] A sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from ANTINEOPLASTIC AGENTS, such as IFOSFA",
"score": 1,
"type": null,
"tokenized_content": [
2,
4438,
2175,
3,
43,
30011,
2199,... |
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 15